ArticleSisli Etfal Hastanesi tip bulteni2026
An Unusual Cause of Ataxia in Patient with Sjogren's Syndrome: Metronidazole Neurotoxicity.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebellar ataxia associated with metronidazole is rare. Sjögren's syndrome (SS), a chronic autoimmune disease, can also rarely present with neurological symptoms such as cerebellar ataxia. In this report, we aimed to present a 40-year-old female patient diagnosed with SS who developed acute-onset speech disorder and imbalance. The patient's complaints developed shortly, four days, after taking metronidazole for a vaginal infection. Her neurological examination revealed a broad-based gait, explosive speech, and bilateral dysmetria. Routine blood tests, nerve conduction studies, and cerebrospinal fluid analysis were normal. Brain magnetic resonance imaging showed hyperintensity in the dentate nuclei of the cerebellum, consistent with metronidazole-induced neurotoxicity. The patient's symptoms rapidly improved after discontinuation of the drug, and the lesions had completely resolved on imaging one month later. Apart from neuropathy and cerebellar degeneration, which are the most common etiologies of ataxia in Sjögren's syndrome, rare metronidazole-induced neurotoxicity was observed in our patient. Metronidazole-induced neurotoxicity may be a potentially reversible cause of cerebellar symptoms, and its recognition based on typical radiological features is important for drug withdrawal and complete recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.